BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 150 filers reported holding BIONTECH SE in Q3 2020. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,209,394 | -13.4% | 103,858 | 0.0% | 0.44% | -11.0% |
| Q1 2023 | $12,937,591 | -17.1% | 103,858 | 0.0% | 0.49% | -16.3% |
| Q4 2022 | $15,601,549 | +21.7% | 103,858 | +9.3% | 0.59% | +12.2% |
| Q3 2022 | $12,819,000 | -9.5% | 95,042 | 0.0% | 0.52% | -5.7% |
| Q2 2022 | $14,171,000 | -12.6% | 95,042 | 0.0% | 0.56% | -2.1% |
| Q1 2022 | $16,210,000 | -30.3% | 95,042 | +5.3% | 0.57% | -24.0% |
| Q4 2021 | $23,264,000 | +5.5% | 90,242 | +11.7% | 0.75% | +5.5% |
| Q3 2021 | $22,046,000 | +72.5% | 80,757 | +41.5% | 0.71% | +71.1% |
| Q2 2021 | $12,778,000 | +70.1% | 57,073 | -17.1% | 0.42% | +60.9% |
| Q1 2021 | $7,514,000 | +149.0% | 68,814 | +57.8% | 0.26% | +128.3% |
| Q3 2020 | $3,018,000 | – | 43,595 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |